Advanced

What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?

Ahrén, Bo LU (2005) In Diabetologia 48. p.605-607
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diabetologia
volume
48
pages
605 - 607
publisher
Springer Verlag
external identifiers
  • wos:000228515900001
  • scopus:17844381917
ISSN
1432-0428
DOI
10.1007/s00125-005-1706-6
language
English
LU publication?
yes
id
fad0dd2f-354a-4d2b-821b-839890c395ff (old id 134929)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15770467&dopt=Abstract
date added to LUP
2007-07-23 15:22:47
date last changed
2017-04-23 03:34:30
@article{fad0dd2f-354a-4d2b-821b-839890c395ff,
  author       = {Ahrén, Bo},
  issn         = {1432-0428},
  language     = {eng},
  pages        = {605--607},
  publisher    = {Springer Verlag},
  series       = {Diabetologia},
  title        = {What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?},
  url          = {http://dx.doi.org/10.1007/s00125-005-1706-6},
  volume       = {48},
  year         = {2005},
}